How much has Colgate-Palmolive raised?

Colgate-Palmolive does not have a relevant startup funding total. Its capital base comes from public equity, retained earnings, debt, and more than two centuries of brand building and global expansion.

The major capital milestones are the 1928 combination that created the modern company and the 1976 Hill's acquisition, which established a major premium pet nutrition platform.

Colgate-Palmolive trades on the NYSE under CL and had a market capitalization around $73 billion in June 2026. The company reported $20.382 billion of 2025 net sales and continued its long dividend-growth record.

Capital goes to advertising, innovation, R&D, manufacturing, packaging, emerging-market distribution, pet nutrition, e-commerce, dividends, share repurchases, debt service, and selective portfolio work. The company balances brand investment with margin discipline and cash generation.

CL valuation moves with organic sales, oral care market share, Hill's pet performance, gross margin, advertising productivity, emerging-market growth, foreign exchange, input costs, dividends, and investor confidence in consumer-staples durability.

Colgate-Palmolive is a strong global buyer, but budget is tied to brand growth, margin, compliance, and consumer trust. Sellers should map to oral care, Hill's, retail media, digital shelf, packaging, sustainability, manufacturing productivity, R&D acceleration, data privacy, or cybersecurity.